1-Acyl-4-benzyl-2,5-transdimethyl-piperazine CCR1 antagonists

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.16, Iss.3, 2006-03, pp. : 395-398

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

CCR1 and CCR2 Antagonists

Current Topics in Medicinal Chemistry, Vol. 14, Iss. 13, 2014-07 ,pp. : 1539-1552

Bentham Science Publishers

Access to resources Recommend Favorite

CCR1 antagonists in clinical development

By Pease James E Horuk Richard

Expert Opinion on Investigational Drugs, Vol. 14, Iss. 7, 2005-07 ,pp. : 785-796

Informa Healthcare

Access to resources Recommend Favorite

Novel chemokine CCR1 receptor antagonists

Expert Opinion on Therapeutic Patents, Vol. 11, Iss. 8, 2001-08 ,pp. : 1355-1357

Informa Healthcare

Access to resources Recommend Favorite

4-Azetidinyl-1-heteroatom linked cyclohexane antagonists of CCR2: patent evaluation

By Horuk Richard Guilford William

Expert Opinion on Therapeutic Patents, Vol. 21, Iss. 8, 2011-08 ,pp. : 1275-1280

Informa Healthcare

Access to resources Recommend Favorite

Small-Molecule Antagonists of CCR5 and CXCR4: A Promising New Class of Anti-HIV-1 Drugs

Current Pharmaceutical Design, Vol. 10, Iss. 17, 2004-07 ,pp. : 2041-2062

Bentham Science Publishers

Access to resources Recommend Favorite